Nanomicelle curcumin improves oxidative stress, inflammatory markers, and assisted reproductive techniques outcomes in endometriosis cases: a randomized clinical trial
Nanomicelle curcumin treatment significantly improved oxidative stress and inflammation markers and enhanced assisted reproductive techniques outcomes in women with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This randomized, placebo-controlled clinical trial studied whether nanomicelle curcumin (120 mg twice daily for 10 weeks) affects oxidative stress markers, pro-inflammatory cytokines, and assisted reproductive techniques (ART) outcomes in 50 women with endometriosis aged 25–35 undergoing ART, with follicular fluid sampled from stage III/IV cases. After treatment, the intervention group showed increased serum antioxidant enzyme activity (TAC, CAT, SOD) and decreased follicular fluid levels of oxidative stress and inflammation markers (MDA, IL-8, TNF-α), alongside improved ART metrics including numbers of oocytes retrieved and mature (MII) oocytes, fertilization, cleavage, and high-quality embryos. The paper’s key caveat is that it provides results based on a relatively small, single-center sample and does not report longer-term outcomes or mechanistic testing beyond these measured biomarkers. This paper is centrally about endometriosis — it is a randomized clinical trial of nanomicelle curcumin targeting oxidative stress, inflammation, and ART outcomes in endometriosis-associated infertility.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
11,610 characters
· extracted from
oa-doi-fallback
· 3 sections
· click to expand
Abstract
References
Acknowledgements
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (49)
- Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies via openalex
- Curcumin and Endometriosis via openalex
- CXC chemokines influence immune surveillance in immunological disorders: Polycystic ovary syndrome and endometriosis via openalex
- Differential expression of follicular fluid cytokines: relationship to subsequent pregnancy in IVF cycles via openalex
- Endometrioma, the follicular fluid inflammatory network and its association with oocyte and embryo characteristics via openalex
- Endometriosis via openalex
- Endometriosis: A Comprehensive Review via openalex
- Endometriosis: An Inflammatory Disease That Requires New Therapeutic Options via openalex
- Endometriosis Is a Cause of Infertility. Does Reactive Oxygen Damage to Gametes and Embryos Play a Key Role in the Pathogenesis of Infertility Caused by Endometriosis? via openalex
- Markers of oxidative stress in follicular fluid of women with endometriosis and tubal infertility undergoing IVF via openalex
- New insights into the pathophysiology of endometriosis: from chronic inflammation to danger signal via openalex
- Relationships Between Concentrations of Tumor Necrosis Factor-α and Nitric Oxide in Follicular Fluid and Oocyte Quality via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Role of Oxidative Stress and Antioxidant Therapies in Endometriosis via openalex
- Therapeutic potential of curcumin in endometrial disorders: Current status and future perspectives via openalex
- Treatment of endometriosis: a review with comparison of 8 guidelines via openalex
- W3011194731 via openalex
- W3053497971 via openalex
- W3088578015 via openalex
- W3093833227 via openalex
- W3134885188 via openalex
- W3180075880 via openalex
- W3185383429 via openalex
- W3197559521 via openalex
- W4205868340 via openalex
- W4226241041 via openalex
- W4281772238 via openalex
- W4293206652 via openalex
- W4309319065 via openalex
- W4320856571 via openalex
- W4322012354 via openalex
- W4366773990 via openalex
- W4387563804 via openalex
- W4392593966 via openalex
- W1569904453 via openalex
- W1975052045 via openalex
- W2090583022 via openalex
- W2109558666 via openalex
- W2162583336 via openalex
- W2165869124 via openalex
- W2633100912 via openalex
- W2779258089 via openalex
- W2792155371 via openalex
- W2794290318 via openalex
- W2971889675 via openalex
- W3003490674 via openalex
- W3006628228 via openalex
- W3008060564 via openalex
- W3008752357 via openalex
Cited by (3)
- Advancing the frontiers of phytotherapy: a comprehensive review of botanical interventions targeting mitochondrial quality control to ameliorate endometriosis 2026
- Critical Considerations and Contemporary Solutions in IVF Management of Women with Endometriosis 2026
- Natural bioactive compounds: Properties and health advantages against numerous medical conditions with a special focus on endometriosis management 2026
Source provenance
- europepmc
- last seen: 2026-08-08T06:08:32.324769+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-08-08T06:05:43.322658+00:00